At least 12 new advanced therapy medicinal products (ATMPs) are expected to get market approval in either the US or the EU over the next 18 months, and there are hundreds more in the pipeline, but a lot needs to be done to prepare healthcare systems for the routine, systematic uptake of these therapies.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?